Daiwa Securities Group’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-293
Closed – – 1409
2025
Q3
$0 Hold
293
– – ﹤0.01% 1364
2025
Q2
$1K Hold
293
– – ﹤0.01% 1270
2025
Q1
$1K Hold
293
– – ﹤0.01% 1236
2024
Q4
$1K Hold
293
– – ﹤0.01% 1260
2024
Q3
$1K Hold
293
– – ﹤0.01% 1254
2024
Q2
$1K Hold
293
– – ﹤0.01% 1295
2024
Q1
$1K Hold
293
– – ﹤0.01% 1299
2023
Q4
$1K Hold
293
– – ﹤0.01% 1302
2023
Q3
$1K Hold
293
– – ﹤0.01% 1264
2023
Q2
$1K Hold
293
– – ﹤0.01% 1286
2023
Q1
$1K Hold
293
– – ﹤0.01% 1265
2022
Q4
$2K Hold
293
– – ﹤0.01% 1231
2022
Q3
$2K Hold
293
– – ﹤0.01% 1238
2022
Q2
$1K Hold
293
– – ﹤0.01% 1304
2022
Q1
$2K Hold
293
– – ﹤0.01% 1262
2021
Q4
$3K Buy
+293
New +$3.15K ﹤0.01% 1251

Other funds holding MXCT

Daiwa Securities Group's MXCT Position: Q4 2025 in Review

Daiwa Securities Group sold out of MaxCyte (MXCT) in Q4 2025, closing a stake of 293 shares.

Daiwa Securities Group first reported a position in MXCT in Q4 2021 and held it in 16 quarters. The position peaked at $3K in Q4 2021. 112 funds tracked by Wall St. Rank hold MXCT as of Q4 2025.

  • Daiwa Securities Group reported no remaining MaxCyte position as of Q4 2025 after selling out during the quarter.
  • Daiwa Securities Group sold 293 MaxCyte shares in Q4 2025.
  • Daiwa Securities Group first reported a position in MaxCyte in Q4 2021 and held it in 16 quarters.
  • Daiwa Securities Group's MaxCyte position peaked at $3K in Q4 2021.
  • 112 funds tracked by Wall St. Rank held MaxCyte as of Q4 2025.

Based on Daiwa Securities Group's 13F filing for Q4 2025, filed 11 Feb 2026.